Broker Notes, Comments and Analysis

Broker notes, analysis and comments

DWF Group “well positioned longer term” says Zeus Capital

DWF Group PLC (LON:DWF) has issued a trading update, indicating that its Commercial business has been hit by COVID-19, with International also not growing to our expectations. While we believe..

Epwin Group COVID-19 update

Epwin Group PLC (LON:EPWN) has announced that it will implement a controlled shut down of its operating facilities for a temporary period in response to the anticipated reduction in demand...

Purplebricks Impact of COVID-19 crisis

What’s new. After an encouraging seasonal increase in Purplebricks Group Plc (LON:PURP) instructions in January and February 2020, activity in recent days has slowed sharply and we see prospects for a..

Arix Bioscience Fiscal 2019 – moving with the times

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

RM Secured Direct Lending Manager presentation at the Hardman & Co Investor Forum

At the Hardman & Co Investor Forum presentation, RMDL summarised the investment opportunity as “RM Secured Direct Lending PLC (LON:RMDL) offers access to a diverse portfolio of secured loans with..

B-North Taking the next steps forward

B-North aims to raise capital ahead of getting its banking licence (due spring 2020) and attacking the huge, profitable and poorly served SME lending market. B-North combines i) state-of-the-art technology..

Haydale Graphene Industries Cost savings continue, revenue growth encouraging

Haydale Graphene Industries PLC (LON:HAYD) commercial traction is improving, medium-term financial issues have now been addressed, and the refocusing and re-orientating of the business with a major cost-saving programme is..

Allergy Therapeutics plc Consistent first-half revenue growth

Allergy Therapeutics PLC (LON:AGY) is a long-established specialist in the prevention, diagnosis and treatment of allergies. Pollinex Quattro (PQ) is an ultra-short course subcutaneous allergy immunotherapy (AIT) platform, which continues..

Pantheon International Plc 2020 interim results: consistency in delivery

The key Pantheon International (LON:PIN) results message was “more of the same”, including: i) market-beating core NAV growth (known given previous disclosures); ii) strong EBITDA growth in underlying companies; iii)..

Primary Health Properties Final results show accelerating rental growth

2019 results were announced on 12 February. 90% of Primary Health Properties PLC (LON:PHP) income is backed by the UK or RoI governments. Occupancy consistently exceeds 99%. We are confident..

Diurnal Group … and more to come (news flow)

Diurnal Group PLC (LON:DNL) is a commercial-stage specialty pharmaceutical company focused on diseases of the endocrine system. Its two lead products are targeting rare conditions where medical need is currently..

Burford Capital Mixture of strong and weak activity in 2019

Burford Capital Limited (LON:BUR) recently released its first-ever trading statement, covering cash activity in 2019. Group-wide commitments set a new record of $1.57bn, a 24% increase. Overall deployments were almost..

Titon Holdings Condititoning

Initiation of our coverage was 16 March 2016 at 101.5p. In February 2018, the price was 215p and it stayed north of £2 for another year. In fiscal 2019, though,..

City of London Investment Group Interim results validate good first half performance

City of London Investment Group (LON:CLIG) has announced its interim results for 1H’20. Several of the key figures were announced in the January trading statement, so the main interest is..

Arix Bioscience With high risk can come high reward

Arix Bioscience PLC (LON:ARIX) is a listed global venture capital (VC) company that presents an opportunity for institutional and retail investors to participate in the high risk-return profile of early-stage..

Neodecortech Well placed for 2020

Neodecortech (NDT) performed well in 2019, in our view, against a difficult economic backdrop with trading picking up in 2H after a tricky 1H. The immediate outlook for 2020 remains..

Advanced Oncotherapy Confidence in LIGHT gaining momentum

The Advanced Oncotherapy PLC (LON:AVO) goal is to deliver an affordable and novel proton beam therapy (PBT) system, based on state-of-the-art technology developed originally at the world-renowned CERN. In the..

Chamberlin Plc Near-term trading subdued

The recent trading update revealed sustained challenging markets. Chamberlin (LON:CMH), however, is still on track strategically, and the group continues to develop its product offering most favourably. The group has..

City of London Investment Group “rise in FUM in January suggests upside to FY20 forecasts” says Zeus Capital

What’s new: City of London Investment Group (LON:CLIG) has published its interim results for the 6 months to 31 December 2019, which are in line with the detailed trading update released..

International Lithium Corp Resource upgrade and happy strategic dilemma

The new resource estimate for the Mariana lithium brine deposit in Argentina transforms its potential into a world-class project in which International Lithium Corp (CVE:ILC) has a 13.7% share (and..

Search

Funds

Broker Notes, Comments and Analysis

Search

Funds

Broker Notes, Comments and Analysis

FTSE 100

Funds